Literature DB >> 30503656

Causal relationship between immunological responses and adverse reactions following vaccination.

Tetsuo Nakayama1.   

Abstract

Vaccine adverse events and controversial safety issues have occurred in recent decades in Japan: aseptic meningitis following the measles-mumps-rubella combined vaccine (MMR), anaphylaxis after immunization with live virus vaccines and inactivated split influenza vaccine, an increased incidence of febrile illness following the simultaneous administration of inactivated vaccines, and chronic pain with neurological illness after immunization with the human papilloma virus vaccine (HPV). Vaccine adverse events are a matter of concern for the public as well as general practitioners; some are within the range of assumptions that adverse reactions after live attenuated vaccines are related to the nature of their parental wild-type viruses. Vaccines stimulate the innate immunity of host immunological defense mechanisms and induce the development of specific acquired immunity. Some adverse events related to autoimmune responses have been reported, such as idiopathic thrombocytopenic purpura and acute disseminated encephalomyelitis (ADEM). Although a plausible relationship was not demonstrated, the possibility of an association cannot be denied. The pathogenicity of adverse reactions was investigated for anaphylactic reactions, systemic and local reactions following vaccinations. Initial innate immune responses are essential for the development of acquired immunity and are related to adverse events from different viewpoints.
Copyright © 2018. Published by Elsevier Ltd.

Entities:  

Keywords:  Adverse events; Adverse reaction; Anaphylaxis; Gelatin allergy; Influenza vaccine

Mesh:

Substances:

Year:  2018        PMID: 30503656     DOI: 10.1016/j.vaccine.2018.11.045

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  14 in total

1.  Principles in Immunology for the Design and Development of Vaccines.

Authors:  Claudius U Meyer; Fred Zepp
Journal:  Methods Mol Biol       Date:  2022

Review 2.  COVID-19 Vaccination and the Rate of Immune and Autoimmune Adverse Events Following Immunization: Insights From a Narrative Literature Review.

Authors:  Naim Mahroum; Noy Lavine; Aviran Ohayon; Ravend Seida; Abdulkarim Alwani; Mahmoud Alrais; Magdi Zoubi; Nicola Luigi Bragazzi
Journal:  Front Immunol       Date:  2022-07-05       Impact factor: 8.786

Review 3.  Polymeric nanoparticle vaccines to combat emerging and pandemic threats.

Authors:  David Wibowo; Sytze H T Jorritsma; Zennia Jean Gonzaga; Benjamin Evert; Shuxiong Chen; Bernd H A Rehm
Journal:  Biomaterials       Date:  2020-12-10       Impact factor: 12.479

Review 4.  In silico T cell epitope identification for SARS-CoV-2: Progress and perspectives.

Authors:  Muhammad Saqib Sohail; Syed Faraz Ahmed; Ahmed Abdul Quadeer; Matthew R McKay
Journal:  Adv Drug Deliv Rev       Date:  2021-01-17       Impact factor: 17.873

5.  Inflammation-related adverse reactions following vaccination potentially indicate a stronger immune response.

Authors:  Chun-Lan Zhuang; Zhi-Jie Lin; Zhao-Feng Bi; Ling-Xian Qiu; Fang-Fang Hu; Xiao-Hui Liu; Bi-Zhen Lin; Ying-Ying Su; Hui-Rong Pan; Tian-Ying Zhang; Shou-Jie Huang; Yue-Mei Hu; You-Lin Qiao; Feng-Cai Zhu; Ting Wu; Jun Zhang; Ning-Shao Xia
Journal:  Emerg Microbes Infect       Date:  2021-12       Impact factor: 7.163

6.  Early safety and tolerability profile of the BNT162b2 COVID-19 vaccine in myasthenia gravis.

Authors:  Itay Lotan; Mark A Hellmann; Yitzhak Friedman; Hadas Stiebel-Kalish; Israel Steiner; Adi Wilf-Yarkoni
Journal:  Neuromuscul Disord       Date:  2022-02-05       Impact factor: 4.296

Review 7.  SARS-CoV-2 reinfection and implications for vaccine development.

Authors:  Firzan Nainu; Rufika Shari Abidin; Muh Akbar Bahar; Andri Frediansyah; Talha Bin Emran; Ali A Rabaan; Kuldeep Dhama; Harapan Harapan
Journal:  Hum Vaccin Immunother       Date:  2020-12-01       Impact factor: 3.452

8.  Methods for predicting vaccine immunogenicity and reactogenicity.

Authors:  Patrícia Gonzalez-Dias; Eva K Lee; Sara Sorgi; Diógenes S de Lima; Alysson H Urbanski; Eduardo Lv Silveira; Helder I Nakaya
Journal:  Hum Vaccin Immunother       Date:  2019-12-23       Impact factor: 3.452

9.  Age and Gender Disparities in Adverse Events Following COVID-19 Vaccination: Real-World Evidence Based on Big Data for Risk Management.

Authors:  Xiaomo Xiong; Jing Yuan; Minghui Li; Bin Jiang; Z Kevin Lu
Journal:  Front Med (Lausanne)       Date:  2021-07-19

10.  Factors Associated with Adverse Reactions to BNT162b2 COVID-19 Vaccine in a Cohort of 3969 Hospital Workers.

Authors:  Mario Rivera-Izquierdo; Eva Soler-Iborte; Javier Pérez de Rojas; María Dolores Pegalajar-García; Ana Gil-Villalba; Ricardo Ruiz-Villaverde; María Del Carmen Valero-Ubierna
Journal:  Vaccines (Basel)       Date:  2021-12-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.